| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.25 | 0.02 |